Every SEC Form 3/4/5 on record for this filer (CIK 1420987) — 6 issuers, 59 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
2 filings failed a price guard — listed below with the reason, excluded from the totals above.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| KYNB | KYNTRA BIO, INC. | Director | 2026-06-17 → 2026-06-17 | 1 | — |
| CNTB | Connect Biopharma Holdings Ltd | Director | 2026-03-16 → 2026-03-16 | 1 | — |
| CLDI | Calidi Biotherapeutics, Inc. | Director | 2023-09-25 → 2025-08-25 | 9 | $150,000 |
| FGEN | FIBROGEN INC | Director | 2016-06-10 → 2025-07-02 | 26 | −$1M |
| ANAB | ANAPTYSBIO, INC | Director · lapsed | 2017-01-25 → 2018-02-06 | 3 | — |
| DEPO | DEPOMED INC | President and CEO · Director · lapsed | 2015-09-29 → 2017-02-10 | 13 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| CLDI | 2025-08-21 | Buy | 75,000 | $2.00 | $150,000 | 76,134 |
| FGEN | 2025-06-30 | Buy | 23,567 | $5.07 | $119,485 | 39,666 |
| FGEN | 2025-03-21 | Buy | 50,000 | $0.34 | $17,000 | 373,722 |
| ⚠ excluded from the dollar totals — reported price $0.34 is more than 50x away from FGEN's own median open-market price ($44.34) — a fat-finger | ||||||
| FGEN | 2025-03-20 | Buy | 250,000 | $0.35 | $87,500 | 323,722 |
| ⚠ excluded from the dollar totals — reported price $0.35 is more than 50x away from FGEN's own median open-market price ($44.34) — a fat-finger | ||||||
3 of 6 issuers are covered and open a security page; the rest are on file here only.
